Drugmakers will soon be able to use data from foreign clinical trials in new drug applications even if trials only compare new products to placebos instead of best available treatments. The change departs from the 1989 Declaration of Helsinki protecting human subjects in clinical research, the FDA's previous standard, according to Integrity in Science Watch.
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Comments